Lucira Health, Inc. Common Stock
LHDX
LHDX was delisted on the 3rd of March, 2023.
51 hedge funds and large institutions have $234M invested in Lucira Health, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 51 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ECG
EPIQ Capital Group
San Francisco,
California
|
+$262M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
+$22.1M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.6M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$11.4M |
| 5 |
FCMV
Foresite Capital Management V
Larkspur,
California
|
+$9.62M |
Top Sellers
LHDX Hedge Fund Activity: Q1 2021 in Review
51 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Lucira Health, Inc. Common Stock (LHDX) for Q1 2021, worth a combined $234M.
Buyers outnumbered sellers: 51 funds opened new LHDX positions and 0 closed out — a net gain of 51 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was EPIQ Capital Group, opening a new position worth an estimated $262M.
- 51 institutional investors held Lucira Health, Inc. Common Stock (LHDX) as of Q1 2021, up from 0 in Q4 2020.
- Funds reported $234M of Lucira Health, Inc. Common Stock stock for Q1 2021.
- 51 funds opened new Lucira Health, Inc. Common Stock positions in Q1 2021 and 0 closed out, a net change of +51 holders.
- The largest Lucira Health, Inc. Common Stock buyer in Q1 2021 was EPIQ Capital Group, an estimated $262M added.
Based on aggregated 13F filings for Q1 2021.